TDS Market

The global TDS (Transdermal Delivery Systems) market was valued at US$ 7.89 billion in 2024 and is projected to reach US$ 12.34 billion by 2030, at a CAGR of 7.74% during the forecast period 2024-2030.

Report Overview

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

TDS Market provides a deep insight into the global TDS (Transdermal Delivery Systems) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global TDS (Transdermal Delivery Systems) Market, TDS Market introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, TDS Market is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the TDS (Transdermal Delivery Systems) market in any manner.

Global TDS (Transdermal Delivery Systems) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Adhex Pharma

Harro Hofliger

Tesa Labtec

Toyochem

Teva Pharmaceutical

Pfizer

IBSA Group

Teikoku Seiyaku

Endo International

Hisamitsu

Mylan

Sorrento Therapeutics

Market Segmentation (by Type)

Single-layer Drug-in-Adhesive

Multi-layer Drug-in-Adhesive

Others

Market Segmentation (by Application)

Hospital

Clinic

Other

Geographic Segmentation